Patents Assigned to Oncobiologics, Inc.
  • ANTIBODIES THAT SPECIFICALLY BIND TO SERUM ALBUMIN WITHOUT INTERFERING WITH ALBUMIN'S CAPABILITY TO INTERACT WITH THE FCRN
    Publication number: 20140186365
    Abstract: Antibodies that specifically bind to an epitope on the serum albumin, including human and/or mouse serum albumin are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 3, 2014
    Applicants: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center, Oncobiologics, Inc.
    Inventors: Matthew K. Robinson, John K. Cini, Jimson W. D'Souza